MPM BioImpact’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRBP
JHC
MPM BioImpact's CRBP Position: Q3 2026 in Review
MPM BioImpact opened a new position in Corbus Pharmaceuticals (CRBP) in Q3 2026: 1,667,272 shares worth $11.4M. The stake represents 0.84% of the portfolio and ranks #35 among its holdings.
116 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.
- MPM BioImpact held 1,667,272 shares of Corbus Pharmaceuticals worth $11.4M as of Q3 2026.
- Corbus Pharmaceuticals was a new MPM BioImpact position in Q3 2026.
- Corbus Pharmaceuticals made up 0.84% of MPM BioImpact's portfolio in Q3 2026, its #35 holding.
- 116 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.
Based on MPM BioImpact's 13F filing for Q3 2026, filed 16 Nov 2026.